Photon counting

Photon Counting, Mobile CT, and More: Unravel the Future of CT Imaging - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023

ResearchAndMarkets.com has added the comprehensive report " Computed Tomography (CT) Markets by Application, by Technology, by Place, and by Product " to its portfolio.

Key Points: 
  • ResearchAndMarkets.com has added the comprehensive report " Computed Tomography (CT) Markets by Application, by Technology, by Place, and by Product " to its portfolio.
  • The world of CT imaging is pushing boundaries with improved capabilities and groundbreaking research results.
  • Photon Counting & Advanced Imaging: As the market veers towards enhanced imaging capabilities like Photon Counting, the question arises, where will advancements head next?
  • Mobile and Point of Care CT: These sectors are emerging as game-changers in the CT landscape, thanks to their remarkable capability and impressive research outcomes.

NeuroLogica Announces a Research Collaboration with Massachusetts General Hospital to Pilot Photon Counting Computed Tomography at the Patient’s Point-Of-Care Using OmniTom Elite CT

Retrieved on: 
Tuesday, July 13, 2021

NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.

Key Points: 
  • NeuroLogica Corp. announced today that its state-of-the-art, OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing multi-energy computed tomography (CT) imaging to the patients point-of-care.
  • View the full release here: https://www.businesswire.com/news/home/20210713005323/en/
    NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care.
  • Pending FDA 510(k) clearance of this technology, Massachusetts General Hospital will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.
  • "We are excited about our collaboration with NeuroLogica, said Raj Gupta, MD, PhD, Director, Ultra-High-Resolution Volume CT Lab, Massachusetts General Hospital.

Gigajot Unveils World's First Commercially Available Quanta Image Sensors

Retrieved on: 
Tuesday, May 18, 2021

b'PASADENA, Calif., May 18, 2021 /PRNewswire/ --Gigajot Technology, inventors of the Quanta Image Sensor (QIS), today announced the first QIS products , marking the dawn of a new era in solid-state imaging.

Key Points: 
  • b'PASADENA, Calif., May 18, 2021 /PRNewswire/ --Gigajot Technology, inventors of the Quanta Image Sensor (QIS), today announced the first QIS products , marking the dawn of a new era in solid-state imaging.
  • Available now, the QIS CDK has a SuperSpeed USB 3.0 interface and user-friendly software, in a small form factor.
  • Capable of true photon counting out of the box, the QIS CDK can be setup in minutes for evaluation or incorporated directly in customer systems.\nAbout Gigajot Technology, Inc.:Headquartered inPasadena, CA, Gigajot is developing the next generation of image sensors.
  • Gigajot\'s mission is to develop innovative Quanta Image Sensor (QIS) devices and advance this technology for the next generation of image sensors, offering high-speed and high-resolution single-photon detection to realize new, unprecedented image capture capabilities for professional, and consumer cameras.

COVID-19 Impacts and Recovery | Insights on the Global Photon Counter Market Research 2021-2025 | Technavio

Retrieved on: 
Thursday, January 28, 2021

The growth of the market segment will be significant during the forecast period.

Key Points: 
  • The growth of the market segment will be significant during the forecast period.
  • By geography, North America is going to have lucrative growth during the forecast period.
  • The increasing demand for devices such as photon counters in the research industry will facilitate the photon counter market growth in North America over the forecast period.
  • The US and Canada are the key markets for Photon Counter in North America.

Samsung Introduces Its Latest Radiology Innovations at RSNA 2020

Retrieved on: 
Monday, November 30, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201130005608/en/
    Samsung at RSNA 2020: Contact in the Untact (Graphic: Business Wire)
    This year has been a pivotal year for Samsung in moving forward new solutions across a variety of areas.
  • Samsung is showcasing its premium digital mobile x-ray, the AccE GM85, which delivers unparalleled performance by improving diagnostic confidence and workflow.
  • In addition, Samsung will be presenting a Photon Counting Detector (PCD)2 cutting-edge technology that measures photons emitted by X-rays.
  • In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world's best IT, image processing, semiconductor and communication technologies into medical devices.

GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition

Retrieved on: 
Friday, November 20, 2020

GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up specializing in photon counting detectors, signifying the companys continued investment in photon counting CT technology.

Key Points: 
  • GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up specializing in photon counting detectors, signifying the companys continued investment in photon counting CT technology.
  • From the first x-ray machines to the first photon counting CT prototype, GE Healthcare is committed to pioneering next generation technologies to achieve precision health and improve lives.
  • Now, photon counting CT technology may have the potential to define the next 50 years of CT innovation.
  • GE Healthcare expects to close the Prismatic Sensors acquisition by January 2021, after holding a minority position in the company since 2017.

EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM

Retrieved on: 
Friday, November 29, 2019

Receipt of FDA 510(k) clearance follows the commercial launch of EOSedge in Europe, Canada and Australia earlier this week.

Key Points: 
  • Receipt of FDA 510(k) clearance follows the commercial launch of EOSedge in Europe, Canada and Australia earlier this week.
  • EOSedge is the first general X-ray system powered by a high-resolution photon counting detector, delivering optimal image quality for outstanding musculoskeletal imaging exams.
  • EOSedge will strengthen the portfolio of the Company, with the first-generation EOS system continuing to be part of the EOS imaging offering.
  • EOS imaging has over 350 system installations in more than 30 countries generating more than 1 million patient exams annually.

Varex To Acquire Leading Linear Array Digital Detector Maker Direct Conversion

Retrieved on: 
Thursday, March 21, 2019

Stockholm-based Direct Conversion, also known by its Ajat and XCounter brands, is a leading manufacturer and marketer of linear array digital detectors utilizing direct conversion and photon counting technology.

Key Points: 
  • Stockholm-based Direct Conversion, also known by its Ajat and XCounter brands, is a leading manufacturer and marketer of linear array digital detectors utilizing direct conversion and photon counting technology.
  • In 2018, Direct Conversion had revenues of 16 million with projected double-digit annual growth rates over the next five years.
  • Direct Conversion also has more than 40 million in signed multi-year supply agreements with customers, primarily for its photon counting detector products.
  • Spencer Gunn, Chief Executive Officer of Direct Conversion AB said, "We are excited to be joining Varex at this point in the growth and expansion of our digital detector array products.